Top Institutes and Centers

The Wistar Institute, ranked 11th among biomedical institutes in the Cure Innovation Index, is an independent biomedical institute in Philadelphia, Pennsylvania. Its market translation standing ranks among the strongest in its category; research capabilities place in the upper tier as well.

Cedars-Sinai Medical Center ranks 12th among biomedical institutes in the Cure Innovation Index. Based in Los Angeles, California, the center places eighth in Research Capabilities among its peers, its strongest domain.

National Jewish Health ranks 13th of 60 biomedical institutes assessed in the Cure Innovation Index, located in Denver, Colorado. The institute's performance is led by market translation and entrepreneurial readiness, both ranking in the upper tier, while research capabilities fall in the lower half of the field.

Beth Israel Deaconess Medical Center ranks 14th among biomedical institutes in the Cure Innovation Index and is based in Boston, Massachusetts. Its profile tilts toward market translation, where it places in the upper tier, supported by a Clinical and Translational Science Award, faculty-led clinical trials, and an incubator with an entrepreneur-in-residence program.

Gladstone Institutes, based in San Francisco, California, ranks 15th among the 60 biomedical institutes assessed by the Cure Innovation Index. The institute places in the upper tier for both market translation and entrepreneurial readiness, while research capabilities land closer to the middle of the field.

Boston Children's Hospital ranks 16th among 60 biomedical institutes in the Cure Innovation Index. Located in Boston, Massachusetts, the hospital performs well across Research Capabilities and Market Translation, ranking ninth in the latter, with a profile that leans toward applied clinical work.

Nationwide Children's Hospital, a pediatric research hospital in Columbus, Ohio, ranks 17th among biomedical institutes in the Cure Innovation Index. The hospital places above average across all three domains, with its strongest standing in Research Capabilities and consistent performance in Market Translation and Entrepreneurial Readiness.

H. Lee Moffitt Cancer Center and Research Institute ranks 18th among biomedical institutes in the Cure Innovation Index, based in Tampa, Florida.

La Jolla Institute for Immunology ranks 19th among biomedical institutes in the Cure Innovation Index, based in San Diego, California. The institute performs consistently across Research Capabilities and Market Translation, with its strongest showing in Entrepreneurial Readiness.

Seattle Children's Hospital ranks 20th among biomedical institutes in the Cure Innovation Index. Located in Seattle, Washington, the institute maintains balanced performance across Research Capabilities and Market Translation, with its strongest standing in Entrepreneurial Readiness, where it places 12th.